Wild-type and innate immune-deficient mice are not susceptible to the Middle East respiratory syndrome coronavirus

References

1. Chan J. F., Chan K. H., Choi G. K., To K. K., Tse H., Cai J. P., Yeung M. L., Cheng V. C., Chen H.other authors 2013; Differential cell line susceptibility to the emerging novel human betacoronavirus 2c EMC/2012: implications for disease pathogenesis and clinical manifestation. J Infect Dis 207:1743–1752 [View Article][PubMed]
   [Google Scholar]
2. Corman V. M., Eckerle I., Bleicker T., Zaki A., Landt O., Eschbach-Bludau M., van Boheemen S., Gopal R., Ballhause M.other authors 2012a; Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Eurosurveillance 17:39[PubMed]
   [Google Scholar]
3. Corman V. M., Muller M. A., Costabel U., Timm J., Binger T., Meyer B., Kreher P., Lattwein E., Eschbach-Bludau M.other authors 2012b; Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Eurosurveillance 1749
   [Google Scholar]
4. de Wit E., Prescott J., Baseler L., Bushmaker T., Thomas T., Lackemeyer M. G., Martellaro C., Milne-Price S., Haddock E.other authors 2013; The Middle East respiratory syndrome coronavirus (MERS-CoV) does not replicate in Syrian hamsters. PLoS ONE 8:e69127 [View Article][PubMed]
   [Google Scholar]
5. Drosten C., Seilmaier M., Corman V. M., Hartmann W., Scheible G., Sack S., Guggemos W., Kallies R., Muth D.other authors 2013; Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis 13:745–751 [View Article][PubMed]
   [Google Scholar]
6. Frieman M. B., Chen J., Morrison T. E., Whitmore A., Funkhouser W., Ward J. M., Lamirande E. W., Roberts A., Heise M.other authors 2010; SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism. PLoS Pathog 6:e1000849 [View Article][PubMed]
   [Google Scholar]
7. Kindler E., Jónsdóttir H. R., Muth D., Hamming O. J., Hartmann R., Rodriguez R., Geffers R., Fouchier R. A., Drosten C.other authors 2013; Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoo-notic potential. mBio 4:e00611–e00612 [View Article][PubMed]
   [Google Scholar]
8. Mailles A., Blanckaert K., Chaud P., van der Werf S., Lina B., Caro V., Campese C., Guéry B., Prouvost H.other authors 2013; First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Eurosurveillance 18:24[PubMed]
   [Google Scholar]
9. Memish Z. A., Zumla A. I., Al-Hakeem R. F., Al-Rabeeah A. A., Stephens G. M. 2013; Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 368:2487–2494 [View Article][PubMed]
   [Google Scholar]
10. Müller M. A., Raj V. S., Muth D., Meyer B., Kallies S., Smits S. L., Wollny R., Bestebroer T. M., Specht S.other authors 2012; Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines. MBio 3:e00515-12 [View Article][PubMed]
    [Google Scholar]
11. Munster V. J., de Wit E., Feldmann H. 2013; Pneumonia from human coronavirus in a macaque model. N Engl J Med 368:1560–1562 [View Article][PubMed]
    [Google Scholar]
12. Perera R., Wang P., Gomaa M., El-Shesheny R., Kandeil A., Bagato O., Siu L., Shehata M., Kayed A.other authors 2013; Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Eurosurveillance 18:18 [View Article][PubMed]
    [Google Scholar]
13. Raj V. S., Mou H., Smits S. L., Dekkers D. H., Müller M. A., Dijkman R., Muth D., Demmers J. A., Zaki A.other authors 2013; Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495:251–254 [View Article][PubMed]
    [Google Scholar]
14. Reed L. J., Muench H. 1938; A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27:493–497
    [Google Scholar]
15. Reusken C. B., Haagmans B. L., Müller M. A., Gutierrez C., Godeke G. J., Meyer B., Muth D., Raj V. S., Vries L. S.other authors 2013; Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis 13:859–866 [View Article][PubMed]
    [Google Scholar]
16. Roberts A., Deming D., Paddock C. D., Cheng A., Yount B., Vogel L., Herman B. D., Sheahan T., Heise M.other authors 2007; A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice. PLoS Pathog 3:e5 [View Article][PubMed]
    [Google Scholar]
17. Sheahan T., Morrison T. E., Funkhouser W., Uematsu S., Akira S., Baric R. S., Heise M. T. 2008; MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV. PLoS Pathog 4:e1000240 [View Article][PubMed]
    [Google Scholar]
18. van Boheemen S., de Graaf M., Lauber C., Bestebroer T. M., Raj V. S., Zaki A. M., Osterhaus A. D., Haagmans B. L., Gorbalenya A. E.other authors 2012; Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3:e00473-12 [View Article][PubMed]
    [Google Scholar]
19. Zielecki F., Weber M., Eickmann M., Spiegelberg L., Zaki A. M., Matrosovich M., Becker S., Weber F. 2013; Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol 87:5300–5304 [View Article][PubMed]
    [Google Scholar]